Some researchers, especially those with higher body weight or prior GLP-1 exposure, may not notice any appetite or metabolic changes at 2mg
nevertheless, human trials are currently absent to verify whether the same advantages manifest outside of laboratory conditions
The fundamental difference is whether GHK-Cu is included
Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI
While we continue to believe in the validity and importance of this measure, and the clinical significance of measuring radiation safety, we acknowledge the current challenges that HOPDs face with respect to the measure's implementation that could necessitate a longer implementation timeframe